JWH-307

From Food & Medicine Encyclopedia

File:JWH-307.svg
JWH-307.svg

JWH-307 is a synthetic cannabinoid from the naphthoylindole family. It acts as a potent agonist for the cannabinoid receptors, with a particular preference for the CB1 receptor.

Chemical Structure[edit]

JWH-307 has the chemical formula C24H22O2 and a molecular weight of 342.43 g/mol. The structure includes a naphthalene ring substituted with a methoxy group and a phenyl ring substituted with a ketone group.

Pharmacology[edit]

JWH-307 is known to bind to the CB1 receptor and CB2 receptor, mimicking the effects of tetrahydrocannabinol (THC), the active component of cannabis. It is part of a class of compounds that were initially developed for research purposes but have since been found in synthetic cannabis products.

Legal Status[edit]

JWH-307 is classified as a Schedule I controlled substance in the United States, indicating that it is considered to have a high potential for abuse and no accepted medical use. In the United Kingdom, it is classified as a Class B drug. It is also controlled under similar regulations in other countries, including Canada and Germany.

Related Compounds[edit]

JWH-307 is part of a larger family of synthetic cannabinoids, including:

See Also[edit]

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.